Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topic search: DOSAGE FORMS/DRUG CARRIERS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

 
Refine your search by entering keywords here:

Dosage Forms and Drug Carrier Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Magic Mouthwashes- A Literature Review and Discussion of Common Compositions
McElhiney Linda F
Mar/Apr 2024
Pg. 94-98

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109

Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G
, Pepin Steven M
Mar/Apr 2024
Pg. 118-119

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
Mar/Apr 2024
Pg. 130

Analgesic Compound Lotion, Clear
Allen Loyd V Jr
Mar/Apr 2024
Pg. 132

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
Mar/Apr 2024
Pg. 133

Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
Mar/Apr 2024
Pg. 134

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
Mar/Apr 2024
Pg. 135

Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications
Spennacchio Antonio
, Lacassia Chiara, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024
Pg. 138-145

Lipophilic Ready-to-use Vehicles and Compounded Topical Medications
Lacassia Chiara
, Spennacchio Antonio, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024
Pg. 146-150

Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base
Lacassia Chiara
, Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Mar/Apr 2024
Pg. 151-155

Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit
Friciu Mihaela
, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire
Mar/Apr 2024
Pg. 156-160

Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia
Marianni Bruna
, Polonini Hudson, Silva Carolina
Mar/Apr 2024
Pg. 169-175

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2024
Pg. 6-14

The Physiologic Role and Use of Estriol
Paoletti Jim E
Jan/Feb 2024
Pg. 16-21

Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
Jan/Feb 2024
Pg. 28-32

Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
Jan/Feb 2024
Pg. 58

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Calculations
Stockton Shelly J
Nov/Dec 2023
Pg. 488

Curcumin 1% Intranasal Mucoadhesive Gel
Allen Loyd V Jr
Nov/Dec 2023
Pg. 490

Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Allen Loyd V Jr
Nov/Dec 2023
Pg. 492

Salicylic Acid 30% Gel
Allen Loyd V Jr
Nov/Dec 2023
Pg. 493

Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash
, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023
Pg. 494-502

Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd
, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 512-521

Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah
, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023
Pg. 522-527

Compounding Metformin for Use in Functional Medicine
Desai Sarina
, Thompson Tara
Sep/Oct 2023
Pg. 362-366

Basics of Compounding: Compounding Foams
Allen Loyd V Jr
Sep/Oct 2023
Pg. 386-395

Crotamiton 10% Cream
Allen Loyd V Jr
Sep/Oct 2023
Pg. 412

Fluconazole 1% Thermoresponsive Gel
Allen Loyd V Jr
Sep/Oct 2023
Pg. 414-415

Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
Sep/Oct 2023
Pg. 417

Povidone Iodine Lotion
Allen Loyd V Jr
Sep/Oct 2023
Pg. 421

Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Baneshi Marzieh
, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Sep/Oct 2023
Pg. 424-430

Topical Vehicles: A Dermatologist's Perspective
Adame Stephanie
, Collins Michael E, Korman Abraham M
Jul/Aug 2023
Pg. 278-283

Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
Jul/Aug 2023
Pg. 316

Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
Jul/Aug 2023
Pg. 317-318

Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
Jul/Aug 2023
Pg. 319

Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
Jul/Aug 2023
Pg. 320-321

Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
Jul/Aug 2023
Pg. 324-325

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2023
Pg. 326

Nystatin Oromucosal Gel
Allen Loyd V Jr
Jul/Aug 2023
Pg. 327

Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban
, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jul/Aug 2023
Pg. 340-346

Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Touprong Robin
, Thompson Tara, Williams LaVonn A
May/Jun 2023
Pg. 182-190

Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
May/Jun 2023
Pg. 218-221

Calculations
Stockton Shelly J
May/Jun 2023
Pg. 230-231

Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2023
Pg. 232-233

Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
May/Jun 2023
Pg. 235

Migraine Headache Suppositories
Allen Loyd V Jr
May/Jun 2023
Pg. 237

Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
May/Jun 2023
Pg. 238

An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Taneja Rajneesh
, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
May/Jun 2023
Pg. 240-249

Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio
, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
May/Jun 2023
Pg. 256-262

PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
Mar/Apr 2023
Pg. 92

Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona
, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2023
Pg. 108-112

Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
Mar/Apr 2023
Pg. 143

Aphthous Ulcer Gel
Allen Loyd V Jr
Mar/Apr 2023
Pg. 144

Cyclosporine Topical Microemulsion
Allen Loyd V Jr
Mar/Apr 2023
Pg. 146

Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
Mar/Apr 2023
Pg. 147

Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
Mar/Apr 2023
Pg. 148

Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
Mar/Apr 2023
Pg. 153

Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry
, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023
Pg. 6-10

Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
Jan/Feb 2023
Pg. 24-29

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
Jan/Feb 2023
Pg. 30-37

Acetaminophen 10 mg/mL for Rectal Use
Allen Loyd V Jr
Jan/Feb 2023
Pg. 50

Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 51

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 52

Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 53

Manning's Liniment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 54

Mayer's Ointment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 55

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jan/Feb 2023
Pg. 56

Psoriasis Topical Ointment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 57

Suspension Solution, Sugar Free
Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig
, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022
Pg. 468-472

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
Nov/Dec 2022
Pg. 508

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377

Calculations
Stockton Shelly J
Sep/Oct 2022
Pg. 420

Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422

Clotrimazole 10-mg Troches
Allen Loyd V Jr
Sep/Oct 2022
Pg. 426

Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke
, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Sep/Oct 2022
Pg. 436-439

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson
, Polonini Hudson
Jul/Aug 2022
Pg. 283-291

Basics: Hollow-type Suppositories
Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
Jul/Aug 2022
Pg. 327

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà
, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
Jul/Aug 2022
Pg. 330-335

Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves
, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2022
Pg. 336-341

A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
May/Jun 2022
Pg. 189-193

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
May/Jun 2022
Pg. 232

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Sirolimus 0.1% Ointment
Allen Loyd V Jr
May/Jun 2022
Pg. 240

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
Mar/Apr 2022
Pg. 92

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren
, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022
Pg. 110-115

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
Mar/Apr 2022
Pg. 141

Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
Mar/Apr 2022
Pg. 142

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
Mar/Apr 2022
Pg. 146

Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 147

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal
, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022
Pg. 155-162

Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral
, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Jan/Feb 2022
Pg. 6-8

A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
Jan/Feb 2022
Pg. 18-23

Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38

Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
Jan/Feb 2022
Pg. 52

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 54

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful
, Ming Long Chiau, Uddin A.B.M. Helal, Sarker Zaidul Islam, Bin Liew Kai
Jan/Feb 2022
Pg. 80-87

Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E
, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021
Pg. 464-467

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472

Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie
, Wright Edward
Nov/Dec 2021
Pg. 482-485

Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 500

Kayexalate in Lactulose
Allen Loyd V Jr
Nov/Dec 2021
Pg. 501

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 325

Moh's Paste, Modified
Allen Loyd V Jr
Jul/Aug 2021
Pg. 326

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jul/Aug 2021
Pg. 327

Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
Jul/Aug 2021
Pg. 328

Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2021
Pg. 329

Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C
, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021
Pg. 336-343

Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Jul/Aug 2021
Pg. 344-351

Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
May/Jun 2021
Pg. 218-221

Stability Evaluation of Minoxidil in FOAMIL Form Base with Bracketing Study Design
Lupatini Rodrigo
, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021
Pg. 236-240

In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D
, Dunbar Jacob R
May/Jun 2021
Pg. 241-245

The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg
, Yoch Doug
Mar/Apr 2021
Pg. 94-98

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
Mar/Apr 2021
Pg. 100-103

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
Mar/Apr 2021
Pg. 126-128

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 143

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes
Walsh Andrea
, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Mar/Apr 2021
Pg. 163-168

Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Mar/Apr 2021
Pg. 169-175

Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S
, Schober Joseph M, McPherson Timothy
Jan/Feb 2021
Pg. 48-51

Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew
, Zhao Fang, Dave Vivek S
Jan/Feb 2021
Pg. 82-87

NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Nov/Dec 2020
Pg. 446-448

Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 482-490

Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations
Kiselova Olga
, Maurina Baiba, Sidlovska Venta
Nov/Dec 2020
Pg. 491-500

Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 501-508

Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract
Azman Syahiera Ezzah Noor
, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Nov/Dec 2020
Pg. 509-514

Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L.
Carneiro Jaqueline
, Marques Gonçalves Melissa, Vicente Pereira Airton
Nov/Dec 2020
Pg. 515-518

Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan
, Perks William, Law Shirley, Iazzetta John, Walker Scott
Nov/Dec 2020
Pg. 519-527

Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung
, Ashworth Lisa Diggs, Goldman Shauna
Sep/Oct 2020
Pg. 367-369

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
Sep/Oct 2020
Pg. 388-395

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2020
Pg. 407

Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli
, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020
Pg. 408-412

Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Sep/Oct 2020
Pg. 413-419

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 282-285

Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
Jul/Aug 2020
Pg. 313

Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun
, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Jul/Aug 2020
Pg. 337-345

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186

Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
May/Jun 2020
Pg. 188-193

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley
, Patel Jalpa
May/Jun 2020
Pg. 242-245

Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
Mar/Apr 2020
Pg. 104-108

Calculations
Stockton Shelly J
Mar/Apr 2020
Pg. 128

The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja
, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2020
Pg. 140-147

Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L
, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020
Pg. 148-155

Feasibility Study of Asthma Cream
Kuang Andrew
Mar/Apr 2020
Pg. 163-167

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 57

LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 59

Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
Nov/Dec 2019
Pg. 472-477

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
Sep/Oct 2019
Pg. 376-381

Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
Sep/Oct 2019
Pg. 393-396

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
Jul/Aug 2019
Pg. 288-293

Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L
, York Anne E
Jul/Aug 2019
Pg. 325-339

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
May/Jun 2019
Pg. 211-216

Trends of Extemporaneous Drug Prescription in Latvia in 2017
Kiselova Olga
, Maurina Baiba, Sidlovska Venta, Rogovska Irena
May/Jun 2019
Pg. 245-249

Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon
, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
May/Jun 2019
Pg. 250-257

Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
Mar/Apr 2019
Pg. 94-104

Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
Mar/Apr 2019
Pg. 113-119

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
Jan/Feb 2019
Pg. 23-31

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 54

Orodispersible Film
Allen Loyd V Jr
Jan/Feb 2019
Pg. 59

Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson
, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019
Pg. 65-69

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C
, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019
Pg. 77-81

Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah
, Agu Remigius U
Jan/Feb 2019
Pg. 82-87

Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn
, Needham Shane
Nov/Dec 2018
Pg. 466-468

Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Cutaia Kara
, Chablani Lipika, Zhao Fang
Nov/Dec 2018
Pg. 480-489

Calculations
Stockton Shelly J
Nov/Dec 2018
Pg. 490

Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience
Apolinário Régis De Souza
, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
Nov/Dec 2018
Pg. 512-515

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2018
Pg. 408

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2018
Pg. 409

Stability of Tranexamic Acid Mouth Rinse
Donnelly Ronald F
Sep/Oct 2018
Pg. 412-416

Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
Jul/Aug 2018
Pg. 294-300

Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 316

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson
, Carvalho Maria, Banov Fabiana
May/Jun 2018
Pg. 182-188

Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E
, Hover Sara, Carvalho Maria
May/Jun 2018
Pg. 196-202

Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
May/Jun 2018
Pg. 220-228

Calculations
Stockton Shelly J
May/Jun 2018
Pg. 230

Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
May/Jun 2018
Pg. 232

Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2018
Pg. 233

Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 235

Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 236

Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
May/Jun 2018
Pg. 237

Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 238

Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 239

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
Mar/Apr 2018
Pg. 137-143

Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel
, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
Mar/Apr 2018
Pg. 154-163

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M
, Brown Michael C, Zavala Pedro J
Jan/Feb 2018
Pg. 41-46

Calculations
Stockton Shelly J
Jan/Feb 2018
Pg. 48

Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
Jan/Feb 2018
Pg. 57

Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
Nov/Dec 2017
Pg. 446-452

Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O
, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017
Pg. 454-461

Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
Nov/Dec 2017
Pg. 471-479

Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 490

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP
, Mishchenko VA, Georgiyants VA
Nov/Dec 2017
Pg. 513-517

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
Sep/Oct 2017
Pg. 408

Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 416

Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 417

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
Jul/Aug 2017
Pg. 293-298

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
Jul/Aug 2017
Pg. 312

Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 313

Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 314

Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 316

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 321

Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia
Robert Julien
, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Jul/Aug 2017
Pg. 347-351

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat
, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017
Pg. 205-211

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R
, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2017
Pg. 242-246

Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
Mar/Apr 2017
Pg. 105-108

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Accuracy Considerations in Sterile Compounding
Akers Michael J
Mar/Apr 2017
Pg. 133-142

Calculations
Stockton Shelly J
Mar/Apr 2017
Pg. 144

Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep
, Light Bob, Purvis Troy
Mar/Apr 2017
Pg. 154-159

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Mar/Apr 2017
Pg. 171-175

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Jan/Feb 2017
Pg. 31-37

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
Jan/Feb 2017
Pg. 63

A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D
, Vernak Charlene, Zhao Fang
Jan/Feb 2017
Pg. 83-87

Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H
, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016
Pg. 461-467

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Calculations
Stockton Shelly J
Nov/Dec 2016
Pg. 502

Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
Nov/Dec 2016
Pg. 507

Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016
Pg. 517-520

Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli
, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2016
Pg. 521-525

Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
Sep/Oct 2016
Pg. 389-396

Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
Sep/Oct 2016
Pg. 407

Naproxen 5% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 410

Permethrin 1% Lotion
Allen Loyd V Jr
Sep/Oct 2016
Pg. 411

Progesterone 10% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 412

Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 414

A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias
, Tal Yana, Amarny Kamal
Sep/Oct 2016
Pg. 438-439

Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
Jul/Aug 2016
Pg. 271-274

Basics of Compounding: Compounding Films
Allen Loyd V Jr
Jul/Aug 2016
Pg. 298-305

Calculations
Stockton Shelly J
Jul/Aug 2016
Pg. 316-317

Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 319

Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 321

Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
Jul/Aug 2016
Pg. 322

1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
Jul/Aug 2016
Pg. 323

Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 324

Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 325

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016
Pg. 347-350

Basics of Compounding: Special Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 209-214

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
May/Jun 2016
Pg. 229

Indomethacin Gel
Allen Loyd V Jr
May/Jun 2016
Pg. 230

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
May/Jun 2016
Pg. 232

Pain-Away II Headache Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 233

Topical Metered-dosing Dispenser Performance Evaluation
Liu Qiang
, Kupiec Thomas C, Vu Nicole T
May/Jun 2016
Pg. 239-246

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Basics of Compounding: Capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 125-134

Formulation and Stability of Solutions
Akers Michael J
Mar/Apr 2016
Pg. 137-141

Calculations
Stockton Shelly J
Mar/Apr 2016
Pg. 142

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 145

Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
Mar/Apr 2016
Pg. 146

Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon
, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Mar/Apr 2016
Pg. 155-158

Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren
, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016
Pg. 159-163

Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata Milap C
Mar/Apr 2016
Pg. 164-166

Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
Jan/Feb 2016
Pg. 6-10

Basic Principles of Lyophilization, Part 2
Akers Michael J
Jan/Feb 2016
Pg. 20-27

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Aprepitant 80-mg Capsules
Allen Loyd V Jr
Jan/Feb 2016
Pg. 48

Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
Jan/Feb 2016
Pg. 49

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
Jan/Feb 2016
Pg. 50

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Mupirocin Calcium 2% Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 52

Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 53

Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
Jan/Feb 2016
Pg. 54

Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 55

A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob
, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2016
Pg. 71-80

Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
Nov/Dec 2015
Pg. 479-484

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
Nov/Dec 2015
Pg. 512

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 404

Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2015
Pg. 405

Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
Sep/Oct 2015
Pg. 406

Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 407

Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 408

Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
Sep/Oct 2015
Pg. 409

Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
Sep/Oct 2015
Pg. 410

Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 411

Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 412

Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 413

Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff
, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015
Pg. 414-419

Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
Sep/Oct 2015
Pg. 428-431

Balsam Peru, Castor Oil, and Trypsin Ointment
Allen Loyd V
Jul/Aug 2015
Pg. 325

Proparacaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V
Jul/Aug 2015
Pg. 332

Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
May/Jun 2015
Pg. 195-203

Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
May/Jun 2015
Pg. 223-230

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
May/Jun 2015
Pg. 244

Stability of Metronidazole Suspensions
Donnelly Ronald F
, Ying James
May/Jun 2015
Pg. 248-251

Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis
, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015
Pg. 252-260

Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
Mar/Apr 2015
Pg. 145

Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
Mar/Apr 2015
Pg. 148

Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M
, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 152-160

Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan
, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015
Pg. 161-166

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
Jan/Feb 2015
Pg. 67

Mupirocin 2% Ointment
Allen Loyd V Jr
Jan/Feb 2015
Pg. 68

Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Pereboom Marieke
, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
Jan/Feb 2015
Pg. 70-72

Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Hadziabdic Jasmina
, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
Jan/Feb 2015
Pg. 78-85

Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula
Sherr Zachary
, Karara Adel H
Nov/Dec 2014
Pg. 462-468

Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
Nov/Dec 2014
Pg. 479-484

Calculations
Stockton Shelly J
Nov/Dec 2014
Pg. 492-493

Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan
, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014
Pg. 504-511

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn
, Maneenuan Duangkhae
Nov/Dec 2014
Pg. 516-519

High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda
, Mamoon Rashid, Nasheed Shams, Mullins Randy
Nov/Dec 2014
Pg. 520-525

PreScription: What is a Compounding Pharmacist?
Allen Loyd V Jr
Sep/Oct 2014
Pg. 356

To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R
, Davidson Gigi S
Sep/Oct 2014
Pg. 366-369

Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill
, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Sep/Oct 2014
Pg. 370-377

Bacitracin Topical Ointment
Allen Loyd V Jr
Sep/Oct 2014
Pg. 409

Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
Sep/Oct 2014
Pg. 415

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William
, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014
Pg. 287-290

Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole
, Lou Jessica R, Kupiec Thomas C
Jul/Aug 2014
Pg. 305-310

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
Jul/Aug 2014
Pg. 318-319

Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C
, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014
Pg. 332-340

Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Hoffmann Brittany
, Carlson Christie, Rao Deepa A
Jul/Aug 2014
Pg. 341-344

Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita
Jul/Aug 2014
Pg. 345-347

Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F
, Sauvageot Jurgita, Addo Richard T
Jul/Aug 2014
Pg. 348-350

A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith
, Tuder Dmitry
May/Jun 2014
Pg. 182-188

Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P
, Muller George
May/Jun 2014
Pg. 190-200

Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole
, Lou Jessica R, Kupiec Thomas
May/Jun 2014
Pg. 213-221

Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
May/Jun 2014
Pg. 228-230

Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
May/Jun 2014
Pg. 235

Dibucaine 1% Ointment
Allen Loyd V Jr
May/Jun 2014
Pg. 236

Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A
, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
May/Jun 2014
Pg. 248-252

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole
, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014
Pg. 123-130

Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
Mar/Apr 2014
Pg. 137-138

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
Jan/Feb 2014
Pg. 42-45

The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D
, Daniels Kelly R
Jan/Feb 2014
Pg. 70-77

Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
Nov/Dec 2013
Pg. 490-495

Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S
, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
Nov/Dec 2013
Pg. 512-514

Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan
, Black Laura
Nov/Dec 2013
Pg. 520-525

Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
Sep/Oct 2013
Pg. 364-368

Chemical Penetration Enhancers
Newton Stephen J
Sep/Oct 2013
Pg. 370-374

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Pruitt Bobby N III
Sep/Oct 2013
Pg. 384-387

Calculations
Stockton Shelly J
, Saluja Hardeep Singh
Sep/Oct 2013
Pg. 412

In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A
, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Sep/Oct 2013
Pg. 424-431

Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
Jul/Aug 2013
Pg. 312-322

Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs
Boonme Prapaporn
, Maneenuan Duangkhae, Channarong Sunee
Jul/Aug 2013
Pg. 347-350

Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
May/Jun 2013
Pg. 201-204

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
Mar/Apr 2013
Pg. 113-123

Stability of Minoxidil in Espumil Foam Base
Geiger Christine M
, Sorenson Bridget, Whaley Paul A
Mar/Apr 2013
Pg. 165-167

Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
Jan/Feb 2013
Pg. 10-22

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2013
Pg. 28-38

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Colds and Cough
Allen Loyd V Jr
Nov/Dec 2012
Pg. 480-483

Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M
, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012
Pg. 510-512

Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations
Ammar Hussein O
, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
Nov/Dec 2012
Pg. 516-523

Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
Sep/Oct 2012
Pg. 386-393

Calculations
Stockton Shelly J
Sep/Oct 2012
Pg. 416

Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Peacock Gina F
, Sauvageot Jurgita
Sep/Oct 2012
Pg. 428-430

Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization
Radojkovic Branko
, Milic Jela, Calija Bojan
Sep/Oct 2012
Pg. 434-437

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
May/Jun 2012
Pg. 196-205

Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A
, Allen Loyd V Jr
May/Jun 2012
Pg. 210-218

In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Lehman Paul A
, Raney Sam G
May/Jun 2012
Pg. 248-252

Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris
, Delano Amy
Mar/Apr 2012
Pg. 110-114

Chemical Stability of Pentoxifylline in a Topical Cream
Gupta Vishnu D
Jan/Feb 2012
Pg. 80-81

Vitamins: Therapy or Hype
Wynn Tom
, Hoffrogge Zach
Jan/Feb 2012
Pg. 17-21

The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2012
Pg. 62-63

Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
Nov/Dec 2011
Pg. 450-457

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D
, Williams LaVonn
Nov/Dec 2011
Pg. 464-469

Calculations
Stockton Shelly J
Nov/Dec 2011
Pg. 498

Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 500

Citric Acid 3% Mouthrinse Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 501

Dapsone 5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2011
Pg. 502

Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Nov/Dec 2011
Pg. 503

Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 507

Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 508

Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
Nov/Dec 2011
Pg. 509

A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather
, Sridhar Vishak, Alexander Kenneth S
Nov/Dec 2011
Pg. 510-514

Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr
, Chetia D
Nov/Dec 2011
Pg. 521-525

Magic Mouthwashes: A Literature Review and Discussion of Common Compositions
McElhiney Linda F
Sep/Oct 2011
Pg. 376-380

Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
Sep/Oct 2011
Pg. 386-387

Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2011
Pg. 418

Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 419

Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 420

Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2011
Pg. 421

Nifedipine 1-mg/500-mg Oral Powder
Allen Loyd V Jr
Sep/Oct 2011
Pg. 422

Nifedipine 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 423

Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 424

Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 425

Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 426

Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 427

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Magnesium Sulfate Paste
Allen Loyd V Jr
Jul/Aug 2011
Pg. 339

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
May/Jun 2011
Pg. 194-199

Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom
, Goetsch Daniel
May/Jun 2011
Pg. 200-203

Treatment Options for Psoriasis
Williams LaVonn A
, Humphreys Erica
May/Jun 2011
Pg. 204-213

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 242

Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 243

Ibuprofen 5% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 244

Sport Body Cooler
Allen Loyd V Jr
May/Jun 2011
Pg. 247

Tannic Acid 5% Alcohol Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 248

Triamcinolone 0.1% Lotion
Allen Loyd V Jr
May/Jun 2011
Pg. 249

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Triclosan 2% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 250

Wound Cleaner Solution
Allen Loyd V Jr
May/Jun 2011
Pg. 251

Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John
, DollbaumCharles M
Mar/Apr 2011
Pg. 102-112

Mandl's Paint
Allen Loyd V Jr
Mar/Apr 2011
Pg. 162

Oral Film Strip Vehicle
Allen Loyd V Jr
Mar/Apr 2011
Pg. 164

Tea Tree Oil Acne Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 165

Nifedpine in Compounded Oral and Topical Preparations
McCluskey Susan V
, Brunn Gregory J
Mar/Apr 2011
Pg. 166-169

PostScription: Commentary: Discussion on the Safety of Topical Prilocaine
Bramwell Bethany L
Mar/Apr 2011
Pg. 174-175

Current Concepts in the Treatment of Recurrent Aphthous Ulcers
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2011
Pg. 13-18

Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos
, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011
Pg. 27-31

Toxicities Associated with Topical Anesthetics
Bramwell Bethany L
Jan/Feb 2011
Pg. 41

Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2011
Pg. 64

Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
Jan/Feb 2011
Pg. 65

Ibuprofen 5% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 66

Mandelic Acid 5% Cream
Allen Loyd V Jr
Jan/Feb 2011
Pg. 67

Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 68

Piroxicam 1% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 69

Pramoxine 1% Cream
Allen Loyd V Jr
Jan/Feb 2011
Pg. 70

Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
Jan/Feb 2011
Pg. 71

Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
Jan/Feb 2011
Pg. 72

Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
Jan/Feb 2011
Pg. 73

Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester
, Zheng Bo, White Catherine A, Li Dawei
Jan/Feb 2011
Pg. 74-77

All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding
Williams KaCee D
Nov/Dec 2010
Pg. 484-486

Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara
, Browne Paul
Nov/Dec 2010
Pg. 488-491

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 514

Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
Nov/Dec 2010
Pg. 517

Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 518

Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2010
Pg. 519

Ketoprofen 2% Oral Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 521

Extemporaneous Compounding of Medicated Ointment
Nagel Karen
, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
Nov/Dec 2010
Pg. 472-478

"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care
Cox Chris
Nov/Dec 2010
Pg. 480-483

Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 520

Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa
, Pankaskie Marvin, Birnie Christine
Nov/Dec 2010
Pg. 522-525

Bioidentical Hormones in the News
Bramwell Bethany L
Sep/Oct 2010
Pg. 374-380

Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients
Muller George
, Case Tyler, Deen Griffin L
Sep/Oct 2010
Pg. 395-399

Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 420

Icy Blue Camphorated Gel
Allen Loyd V Jr
Sep/Oct 2010
Pg. 422

Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 423

Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 424

Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2010
Pg. 421

Triclosan 0.28% Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 425

Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 426

Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 427

Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 428

Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
Sep/Oct 2010
Pg. 429

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
Jul/Aug 2010
Pg. 270-274

Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
Jul/Aug 2010
Pg. 276-282

Considerations for Percutaneous Absorption
Newton Stephen J
, Cook Jennifer M
Jul/Aug 2010
Pg. 301-304

Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
Jul/Aug 2010
Pg. 334

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel
, White Lyndell
Jul/Aug 2010
Pg. 310-314

Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
Jul/Aug 2010
Pg. 322-326

Ampicillin 250-mg Suppository
Allen Loyd V Jr
Jul/Aug 2010
Pg. 335

Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2010
Pg. 336

Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
Jul/Aug 2010
Pg. 341

Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping
Tong Henry H Y
, Chan Hokman, Du Zhen, Zheng Ying
Jul/Aug 2010
Pg. 342-345

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Managing Pain with Transdermal Ketoprofen
Williams KaCee D
May/Jun 2010
Pg. 204-206

Potential Treatments for Radiation Dermatitis
Corsini Lindsay
May/Jun 2010
Pg. 210-213

Calculations
Stockton Shelly J
May/Jun 2010
Pg. 230

Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2010
Pg. 240

Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
May/Jun 2010
Pg. 241

Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 242

Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 243

Cohen's Rectal Ointment
Allen Loyd V Jr
May/Jun 2010
Pg. 244

Cyclophosphamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 245

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 247

Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 248

Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
May/Jun 2010
Pg. 249

Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M
, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
May/Jun 2010
Pg. 250-256

Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
Mar/Apr 2010
Pg. 112-115

Acyclovir 5% in Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 150

Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
Mar/Apr 2010
Pg. 151

Ciclopirox 10% in Isopropyl Alcohol Nail Solution
Allen Loyd V Jr
Mar/Apr 2010
Pg. 152

Clotrimazole 1% Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 153

Cyclosporin 10-mg/g in Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 154

Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
Mar/Apr 2010
Pg. 155

Plasticized Hydrocarbon Gel
Allen Loyd V Jr
Mar/Apr 2010
Pg. 158

Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 159

Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F
, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010
Pg. 21-25

Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George
, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010
Pg. 40-45

Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
Jan/Feb 2010
Pg. 68

Metronidazole in Normal Saline Enema
Allen Loyd V Jr
Jan/Feb 2010
Pg. 69

Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
Jan/Feb 2010
Pg. 70

Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 72

Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 73

Trigger Point Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 75

When Traditional Medicine Fails
Bash Robert
Jan/Feb 2010
Pg. 6-8

Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2010
Pg. 74

Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
Nov/Dec 2009
Pg. 554

Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
Nov/Dec 2009
Pg. 555

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Ichthammol 10% Otic Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 557

The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J
, Asbill Scott
Nov/Dec 2009
Pg. 569-571

Lubow's Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 558

Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
Nov/Dec 2009
Pg. 559

Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2009
Pg. 560

Twevan Cream
Allen Loyd V Jr
Nov/Dec 2009
Pg. 561

Voriconazole 2% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 562

Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes
Bailey Caroline
, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Nov/Dec 2009
Pg. 564-568

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
Nov/Dec 2009
Pg. 572-573

Transdermal Dosing Considerations for Veterinarians
Williams KaCee D
Sep/Oct 2009
Pg. 358-360

Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A
, Riley Kari
Sep/Oct 2009
Pg. 367-371

Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L
, Williams LaVonn A
Sep/Oct 2009
Pg. 390-391

Aceclofenac 1.5% Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 428

Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
Sep/Oct 2009
Pg. 432

Lidocaine 10% Oral Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 433

Mechlorethamine Hydrochloride 0.02% Topical
Allen Loyd V Jr
Sep/Oct 2009
Pg. 434

Myristyl Nicotinate 5% Topical Gel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 435

Nitroglycerin 4-mg Suppository
Allen Loyd V Jr
Sep/Oct 2009
Pg. 436

Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
Sep/Oct 2009
Pg. 438-439

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L
, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009
Pg. 314-317

Moxifloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2009
Pg. 337

Mupirocin 1% (20-mg) Vaginal Suppository
Allen Loyd V Jr
Jul/Aug 2009
Pg. 338

Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
Jul/Aug 2009
Pg. 340

Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison
Chauhan Harsh
, Atef Eman
Jul/Aug 2009
Pg. 342-344

Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Spark M Joy
, Dunn Rebecca A, Houlahan Kelli L
Jul/Aug 2009
Pg. 345-349

The Physiologic Role and Use of Estriol
Paoletti Jim E
Jul/Aug 2009
Pg. 270-275

Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
Jul/Aug 2009
Pg. 276-279

Alcohol-based Carbomer Gel
Allen Loyd V Jr
Jul/Aug 2009
Pg. 332

Benzoyl Peroxide 10% Gel
Allen Loyd V Jr
Jul/Aug 2009
Pg. 333

Clindamycin 100-mg Vaginal Suppositories
Allen Loyd V Jr
Jul/Aug 2009
Pg. 334

Dexamethasone and Furosemide Injection
Allen Loyd V Jr
Jul/Aug 2009
Pg. 335

Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula
, Dimassi Hani
May/Jun 2009
Pg. 259-261

Update on Managing Neuropathic Pain
McNulty Jack P
, Muller George
May/Jun 2009
Pg. 182-190

Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids
Zur Eyal
May/Jun 2009
Pg. 192-195

Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Muller George
, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
May/Jun 2009
Pg. 196-213

Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L
, Bogner Robin H
May/Jun 2009
Pg. 214-217

Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G
, Pepin Steven M
May/Jun 2009
Pg. 218-219

Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
May/Jun 2009
Pg. 220-221

Analgesic Compound Lotion, Clear
Allen Loyd V Jr
May/Jun 2009
Pg. 240

Hydromorphone Hydrochloride 10-mg/mL Oral Drops
Allen Loyd V Jr
May/Jun 2009
Pg. 241

Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Garg Sanjay
, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
May/Jun 2009
Pg. 250-253

Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Shank Brandon R
, Ofner Clyde M III
May/Jun 2009
Pg. 254-258

Lidocaine 2% Popsicle
Allen Loyd V Jr
May/Jun 2009
Pg. 242

Morphine Sulfate 10-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2009
Pg. 243

Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
May/Jun 2009
Pg. 244

Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
May/Jun 2009
Pg. 245

Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 246

Oxycodone Hydrochloride 20-mg Suppository
Allen Loyd V Jr
May/Jun 2009
Pg. 247

Promethazine 20-mg and Acetaminophen 325-mg Suppositories
Allen Loyd V Jr
May/Jun 2009
Pg. 248

Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 249

Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule
Haywood Alison
, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
Mar/Apr 2009
Pg. 170-174

Aprepitant 20-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2009
Pg. 153

Chloroquine Phosphate 64.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 154

Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation
Allen Loyd V Jr
Mar/Apr 2009
Pg. 155

Ionic Hydration Solution for Anti-Cancer Therapy
Allen Loyd V Jr
Mar/Apr 2009
Pg. 156

Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 157

Nicotine Rectal Enema
Allen Loyd V Jr
Mar/Apr 2009
Pg. 158

Thiothixene Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 159

Tolterodine 2-mg/5-mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2009
Pg. 160

Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 161

Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William
, Angelle Patricea, Yoch Douglas
Jan/Feb 2009
Pg. 6-12

Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R
, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009
Pg. 14-18

Compounding with Sucralfate for the Treatment of External Wounds
Wynn Tom
, Williams LaVonn A
Jan/Feb 2009
Pg. 25-29

Identifying the Criteria of a Valid Stability Study
Williams LaVonn A
, Hastings Mitchell Blaine
Jan/Feb 2009
Pg. 32-36

Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
Jan/Feb 2009
Pg. 64

Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 65

Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel
Allen Loyd V Jr
Jan/Feb 2009
Pg. 66

Dextromethorphan Hydrobromide 30-mg Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 67

Diaper Rash Cream with Miconazole
Allen Loyd V Jr
Jan/Feb 2009
Pg. 68

Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 69

Electrolyte Lollipop (Adult)
Allen Loyd V Jr
Jan/Feb 2009
Pg. 70

Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
Jan/Feb 2009
Pg. 71

Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 72

Tetracaine 0.025% Popsicles
Allen Loyd V Jr
Jan/Feb 2009
Pg. 73

Testing of Estradiol in a Compounded Cream and a Stock Solution
Buderer Matthew J
, Buderer Nancy M
Jan/Feb 2009
Pg. 74-77

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
Sep/Oct 2008
Pg. 446

Acetaminophen 10-mg/mL Rectal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 447

Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 449

Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 450

Flurandrenolide Topical Film
Allen Loyd V Jr
Sep/Oct 2008
Pg. 451

Ketoprofen 20% Topical Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 452

Lidocaine Adhesive System Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 453

Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
Sep/Oct 2008
Pg. 454

Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2008
Pg. 455

Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
Nov/Dec 2008
Pg. 482-487

Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert
, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008
Pg. 498-504

Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 543

Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 544

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 540

Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 541

Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
Nov/Dec 2008
Pg. 549

Zirconium Oxide Lotion
Allen Loyd V Jr
Jul/Aug 2008
Pg. 364

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia
, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008
Pg. 365-367

Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
Jul/Aug 2008
Pg. 372-374

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C
, Vu Nicole, Branscum David
Jul/Aug 2008
Pg. 340-343

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
Jul/Aug 2008
Pg. 355

Silicone Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 356

Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 357

Squalene 0.2% Cream
Allen Loyd V Jr
Jul/Aug 2008
Pg. 358

Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
Jul/Aug 2008
Pg. 359

Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 360

Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 361

Ultrasonic Adhesive Gel
Allen Loyd V Jr
Jul/Aug 2008
Pg. 362

Vitamin A Suppository
Allen Loyd V Jr
Jul/Aug 2008
Pg. 363

African Scalp Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 260

Benzyl Benzoate Lotion
Allen Loyd V Jr
May/Jun 2008
Pg. 261

Calcium Gluconate 2.5% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 262

Lubricating Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 263

Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 264

Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
May/Jun 2008
Pg. 265

Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
May/Jun 2008
Pg. 266

Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2008
Pg. 267

Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
May/Jun 2008
Pg. 268

Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2008
Pg. 269

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
May/Jun 2008
Pg. 192-197

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S
, Banov Daniel, Lehman Paul A
May/Jun 2008
Pg. 270-273

Acyclovir 5% Topical Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 146

Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson
, Holandino Carla
Mar/Apr 2008
Pg. 163-169

Alum 6.5% Topical Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 147

Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 148

Butesin Picrate 1% ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 149

Carbamazepine Topical Preparations
Allen Loyd V Jr
Mar/Apr 2008
Pg. 150

Chlorhexidine Gel
Allen Loyd V Jr
Mar/Apr 2008
Pg. 151

EDTA 1% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 152

Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
Mar/Apr 2008
Pg. 153

Heparin Gel-Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 154

Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
Mar/Apr 2008
Pg. 155

Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G
, Abdulmohsin Saud
Jan/Feb 2008
Pg. 8-14

Cyclosporine Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 64

Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 65

Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 66

Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
Jan/Feb 2008
Pg. 67

Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 68

Flosulide 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2008
Pg. 69

Pentoxifylline 20-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 70

Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 71

Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
Jan/Feb 2008
Pg. 72

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2008
Pg. 73

Aloe Vera Gel
Allen Loyd V Jr
Nov/Dec 2007
Pg. 504

Breast Care Cream
Allen Loyd V Jr
Nov/Dec 2007
Pg. 505

Castor Oil and Trypsin Ointment
Allen Loyd V Jr
Nov/Dec 2007
Pg. 506

Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M
, Reed Thomas C
Nov/Dec 2007
Pg. 514-519

Chlorhexidine 2% Gel
Allen Loyd V Jr
Nov/Dec 2007
Pg. 507

Coal Tar 2% and Allantoin 2.5% Cream
Allen Loyd V Jr
Nov/Dec 2007
Pg. 508

Foscarnet 2.5% Topical Cream
Allen Loyd V Jr
Nov/Dec 2007
Pg. 509

Interferon alfa-2b Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2007
Pg. 510

Miconazole 2% Oral Gel
Allen Loyd V Jr
Nov/Dec 2007
Pg. 512

Rabbit Medicine
Jordan Dinah G
Sep/Oct 2007
Pg. 364-374

Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
Sep/Oct 2007
Pg. 416

Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 419

Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
Sep/Oct 2007
Pg. 420

Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2007
Pg. 421

Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 423

Neomycin 0.05% Topical Gel
Allen Loyd V Jr
Sep/Oct 2007
Pg. 424

Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C
, Asbill C Scott, Webster Andrew A
Sep/Oct 2007
Pg. 433-437

Ketoconazole 25-mg Liquid Suppository
Allen Loyd V Jr
Jul/Aug 2007
Pg. 329

Mebeverine Hydrochloride 20% gel
Allen Loyd V Jr
Jul/Aug 2007
Pg. 330

Oseltamivir 12-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2007
Pg. 332

Phenytoin Sodium 20-mg/mL Topical Suspension
Allen Loyd V Jr
Jul/Aug 2007
Pg. 333

Vehicle N Formulas
Allen Loyd V Jr
Jul/Aug 2007
Pg. 337

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Calculations - Compounding for Pain Management
Stockton Shelly J
May/Jun 2007
Pg. 238-239

Benazepril 2-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 242

Cholecalciferol 40,000-IU/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 243

Folic Acid 1-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 244

Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 245

Isoproterenol Compound Elixir
Allen Loyd V Jr
May/Jun 2007
Pg. 246

Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 247

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 248

Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 249

Thiamine Hydrochloride 100-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 250

Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 251

Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla
, Wynn Tom
May/Jun 2007
Pg. 181-184

Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
May/Jun 2007
Pg. 187-192

The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vail Jane
May/Jun 2007
Pg. 194-199

Insulins: Historical and Current Perspectives
Vance Dwight A
Mar/Apr 2007
Pg. 95-104

Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh
Vail Jane
Mar/Apr 2007
Pg. 106-110

Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Fields Shannon W
Mar/Apr 2007
Pg. 122-124

Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
Mar/Apr 2007
Pg. 131

Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
Mar/Apr 2007
Pg. 145-148

Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
Mar/Apr 2007
Pg. 132-135

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 5-8

Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine
, Moffett Brady S
Jan/Feb 2007
Pg. 17-19

Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
Jan/Feb 2007
Pg. 27

Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 69

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 71

Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 72

Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 73

Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 74

Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 75

Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 76

Chemical Stability of Desonide in Ear Drops
Gupta Vishnu D
Jan/Feb 2007
Pg. 79-81

BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
Nov/Dec 2006
Pg. 428-433

Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
Nov/Dec 2006
Pg. 434-435

Chloral Hydrate 50-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 453

Cyclophosphamide 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 454

Disulfiram 25-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 455

Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 456

Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 457

Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 458

Naltrexone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 459

Terbutaline Sulfate 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 460

Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 461

Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Piette Marie
, Stassen Thibaut, Kinget Renaat, Delattre Luc
Nov/Dec 2006
Pg. 469-477

Compounding for Feline Herpetic Keratitis
Davidson Gigi S
Nov/Dec 2006
Pg. 411-414

Compounding for Veterinary Medicine
Fields Shannon W
Nov/Dec 2006
Pg. 417-418

Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
Nov/Dec 2006
Pg. 418

Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
Nov/Dec 2006
Pg. 421-424

Amiloride Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 452

Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
Sep/Oct 2006
Pg. 324-328

Dermatological Effects from Years in the Sun: Compounding Opportunities
Jones Marty
Sep/Oct 2006
Pg. 336-342

Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
Sep/Oct 2006
Pg. 351

In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
Sep/Oct 2006
Pg. 392-395

Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A
, Zhang Yanping, Koontz Susannah E
Sep/Oct 2006
Pg. 396-399

Compounded Treatment Options for Cystitis and Other Bladder Problems
McElhiney Linda F
Jul/Aug 2006
Pg. 270-275

Hospice Symptom Relief Kit: An Update
Petrin Ronald L
Jul/Aug 2006
Pg. 288-290

Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 299

Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 300

Itraconazole 40-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 301

Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 302

Nifedipine 4-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 303

Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 304

Sildenafil Citrate 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 306

Tramadol Hydrochloride 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 307

Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2006
Pg. 308

Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong Weeranuj
, Teixeira M Glaucia, Mayer Gabriele E
Jul/Aug 2006
Pg. 316-317

Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana
, Kirshbaum Karen
May/Jun 2006
Pg. 165-171

Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 202-204

Basics of Compounding for Dentistry, Part 2: Tooth Whitening
Fonseca Simonne C
May/Jun 2006
Pg. 205-207

Triamcinolone Acetonide 0.1% Mouthwash Solution
Allen Loyd V Jr
May/Jun 2006
Pg. 229

Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Tolen Laura
, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
Mar/Apr 2006
Pg. 147-153

ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
Mar/Apr 2006
Pg. 95-98

Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations
Fonseca Simonne C
Mar/Apr 2006
Pg. 122-127

Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
Jan/Feb 2006
Pg. 9-11

Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
Jan/Feb 2006
Pg. 14-18

View Sample
Chlorambucil 2-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 59

Dantrolene Sodium 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 60

Domperidone 1-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 61

Efavirenz 20-mg/mL Oral Liquid, Anhydrous
Allen Loyd V Jr
Jan/Feb 2006
Pg. 62

Medium-Chain Triglycerides Oral Vehicle, Anhydrous
Allen Loyd V Jr
Jan/Feb 2006
Pg. 63

Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 64

Misoprostol 1-mg Suppository
Allen Loyd V Jr
Jan/Feb 2006
Pg. 65

Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 66

Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 67

Thioguanine 40-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2006
Pg. 68

Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
Nov/Dec 2005
Pg. 410

Unlocking Autism: Is Compounding the Key?
Vail Jane
Nov/Dec 2005
Pg. 413-420

Compounding for a Pediatric Hospital
McElhiney Linda F
Nov/Dec 2005
Pg. 423-431

Wiping Out Diaper Rash
Fields Shannon W
Nov/Dec 2005
Pg. 433-434

View Sample
Pediatric Oral Liquid Preparations
Fonseca Simonne C
, Ferreira Anderson de O
Nov/Dec 2005
Pg. 437-442

Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 472

Bethanechol 5-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 473

Clonazepam 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 474

Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 475

Ganciclovir 100-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 476

Isradipine 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 477

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461

Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Allen Loyd V Jr
Nov/Dec 2005
Pg. 462-469

Pyrazinamide 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 478

Quinidine Sulfate 10-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 479

Ursodiol 25-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 480

Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 481

Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
Nov/Dec 2005
Pg. 484-486

A Patient's Guide to Transdermal Treatment of Pain
Fields Shannon W
Sep/Oct 2005
Pg. 354

Update on Transdermals for Animal Patients
Davidson Gigi S
May/Jun 2005
Pg. 178-182

View Sample
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions
Fonseca Simonne C
May/Jun 2005
Pg. 215-218

Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K
, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2005
Pg. 242-246

Return to Top